mutations specified The point that, as discussed under, CLL therapy relies around the existence or absence of these mutations. The present consensus is the fact that, in addition to clonal mutations, subclonal mutations having a variant allelic frequency starting from 5 to 10% (and for that reason down below the threshold of detection by regular mo